From Texas Health and Human Services Commission <[email protected]>
Subject July 2022 Drug Utilization Review Board Meeting Summary
Date August 12, 2022 1:01 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Texas Health and Human Services [ [link removed] ]

Blue Gradient


July 2022 Drug Utilization Review Board Meeting Summary

The Texas Drug Utilization Review Board met Friday, July 22, to make recommendations about clinical prior authorizations and drugs on the Texas Medicaid Preferred Drug List. A summary of the meeting is now available [ [link removed] ].

*Other news*


* Hepatitis C Treatment Coverage and PDL Update Scheduled for September 1 [ [link removed] ]
* Clinical Prior Authorization for Xenical No Longer Required After September 12 [ [link removed] ]
* Clinical Prior Authorization Assistance Chart Now Available [ [link removed] ]

 









________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis